Collectins, H-ficolin and LL-37 reduce influence viral replication in human monocytes and modulate virus-induced cytokine production

Does a Personal or Family History of Malignancy Preclude the Use of Immunomodulators and Biologics in IBD

(2015) Richard S. Kalman et al.   INFLAMMATORY BOWEL DISEASES

Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses

(2014) Nikolaos M. Nikolaidis et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Multimerization of Surfactant Protein D, but Not Its Collagen Domain, Is Required for Antiviral and Opsonic Activities Related to Influenza Virus

(2014) M. White et al.   JOURNAL OF IMMUNOLOGY

CCR2+ Monocyte-Derived Dendritic Cells and Exudate Macrophages Produce Influenza-Induced Pulmonary Immune Pathology and Mortality

(2014) K. L. Lin et al.   JOURNAL OF IMMUNOLOGY

LL-37 modulates human neutrophil responses to influenza A virus

(2014) Shweta Tripathi et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Molecular Mechanisms of Inhibition of Influenza by Surfactant Protein D Revealed by Large-Scale Molecular Dynamics Simulation

(2013) Boon Chong Goh et al.   BIOCHEMISTRY

The amazing innate immune response to influenza A virus infection

(2013) Shweta Tripathi et al.   Innate Immunity

Depletion of Alveolar Macrophages during Influenza Infection Facilitates Bacterial Superinfections

(2013) H. E. Ghoneim et al.   JOURNAL OF IMMUNOLOGY

Efficacy of recombinant chimeric lectins, consisting of mannose binding lectin and L-ficolin, against influenza A viral infection in mouse model study

(2013) Kazue Takahashi et al.   VIRUS RESEARCH

Studies of the Pattern Recognition Molecule H-ficolin

(2012) Rikke M. Zacho et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins

(2012) S. Tripathi et al.   JOURNAL OF GENERAL VIROLOGY

Human H-Ficolin Inhibits Replication of Seasonal and Pandemic Influenza A Viruses

(2012) A. Verma et al.   JOURNAL OF IMMUNOLOGY

L-Ficolin Binds to the Glycoproteins Hemagglutinin and Neuraminidase and Inhibits Influenza A Virus Infection Both in vitro and in vivo

(2012) Qin Pan et al.   Journal of Innate Immunity

Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A Infection

(2012) Stéphane G. Paquette et al.   PLoS One

Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection

(2011) Wei-Chuan Chang et al.   BMC IMMUNOLOGY

Mutagenesis of Surfactant Protein D Informed by Evolution and X-ray Crystallography Enhances Defenses against Influenza A Virusin Vivo

(2011) Erika Crouch et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Host Defense Peptide LL-37 Selectively Reduces Proinflammatory Macrophage Responses

(2011) K. L. Brown et al.   JOURNAL OF IMMUNOLOGY

Specific Sites of N-Linked Glycosylation on the Hemagglutinin of H1N1 Subtype Influenza A Virus Determine Sensitivity to Inhibitors of the Innate Immune System and Virulence in Mice

(2011) M. D. Tate et al.   JOURNAL OF IMMUNOLOGY

Critical Role of SerpinB1 in Regulating Inflammatory Responses in Pulmonary Influenza Infection

(2011) Dapeng Gong et al.   JOURNAL OF INFECTIOUS DISEASES

Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37

(2011) Peter G. Barlow et al.   PLoS One

The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding

(2011) Li Qi et al.   VIROLOGY

Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin

(2010) Wei-Chuan Chang et al.   BIOCHEMICAL PHARMACOLOGY

A Novel L-ficolin/Mannose-binding Lectin Chimeric Molecule with Enhanced Activity against Ebola Virus

(2010) Ian C. Michelow et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CCR2-Antagonist Prophylaxis Reduces Pulmonary Immune Pathology and Markedly Improves Survival during Influenza Infection

(2010) K. L. Lin et al.   JOURNAL OF IMMUNOLOGY

Recognition of Mannosylated Ligands and Influenza A Virus by Human Surfactant Protein D: Contributions of an Extended Site and Residue 343†,‡

(2009) Erika Crouch et al.   BIOCHEMISTRY

Interactions of  -,  -, and  -Defensins with Influenza A Virus and Surfactant Protein D

(2009) M. Doss et al.   JOURNAL OF IMMUNOLOGY

Immunodeficiency Associated withFCN3Mutation and Ficolin-3 Deficiency

(2009) Lea Munthe-Fog et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus

(2009) C. R. Baskin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection

(2009) J. R. Aldridge et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Alveolar Macrophages Are Indispensable for Controlling Influenza Viruses in Lungs of Pigs

(2008) H. M. Kim et al.   JOURNAL OF VIROLOGY

H5N1 and 1918 Pandemic Influenza Virus Infection Results in Early and Excessive Infiltration of Macrophages and Neutrophils in the Lungs of Mice

(2008) Lucy A. Perrone et al.   PLoS Pathogens

Expression of M-Ficolin in human monocytes and macrophages

(2007) Marion Frankenberger et al.   MOLECULAR IMMUNOLOGY